Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study.
Rev Neurol (Paris). 2021 Dec;177(10):1250-1261. doi: 10.1016/j.neurol.2021.04.006. Epub 2021 Jul 10.
Rev Neurol (Paris). 2021.
PMID: 34253346